Role of Diagnostic Nerve Blocks in the Goal-Oriented Treatment of Spasticity with Botulinum Toxin Type A: A Case-Control Study.


Journal

Toxins
ISSN: 2072-6651
Titre abrégé: Toxins (Basel)
Pays: Switzerland
ID NLM: 101530765

Informations de publication

Date de publication:
03 Jun 2024
Historique:
received: 16 04 2024
revised: 17 05 2024
accepted: 28 05 2024
medline: 26 6 2024
pubmed: 26 6 2024
entrez: 26 6 2024
Statut: epublish

Résumé

The goal-setting process is pivotal in managing patients with disabling spasticity. This case-control study assessed the role of diagnostic nerve blocks in guiding the goal-setting process within goal-targeted treatment of spasticity with botulinum neurotoxin-A. In this case-control study, patients with disabling spasticity underwent either a goal-setting process based on the patient's needs and clinical evaluation (control group) or additional diagnostic nerve block procedures (case group). All enrolled patients underwent a focal treatment with botulinum neurotoxin-A injection and a 1-month follow-up evaluation during which goal achievement was quantified using the goal attainment scaling-light score system. Data showed a higher goal achievement rate in the case group (70%) than in the control group (40%). In conclusion, diagnostic nerve blocks may help guide the goal-setting process within goal-targeted treatment of spasticity with botulinum neurotoxin-A towards more realistic and achievable goals, thereby improving the outcomes of botulinum neurotoxin-A injection. Future studies should better explore the role of diagnostic nerve blocks to further personalize botulinum neurotoxin-A according to individual patients' preferences and requirements.

Identifiants

pubmed: 38922151
pii: toxins16060258
doi: 10.3390/toxins16060258
pii:
doi:

Substances chimiques

Botulinum Toxins, Type A EC 3.4.24.69
Neuromuscular Agents 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Auteurs

Mirko Filippetti (M)

Department of Neurosciences, Biomedicine and Movement Sciences, University of Verona, 37100 Verona, Italy.

Stefano Tamburin (S)

Department of Neurosciences, Biomedicine and Movement Sciences, University of Verona, 37100 Verona, Italy.

Rita Di Censo (R)

Department of Neurosciences, Biomedicine and Movement Sciences, University of Verona, 37100 Verona, Italy.

Martina Adamo (M)

Department of Neurosciences, Biomedicine and Movement Sciences, University of Verona, 37100 Verona, Italy.

Elisa Manera (E)

Department of Neurosciences, Biomedicine and Movement Sciences, University of Verona, 37100 Verona, Italy.

Jessica Ingrà (J)

Department of Neurosciences, Biomedicine and Movement Sciences, University of Verona, 37100 Verona, Italy.

Elisa Mantovani (E)

Department of Neurosciences, Biomedicine and Movement Sciences, University of Verona, 37100 Verona, Italy.

Salvatore Facciorusso (S)

Spasticity and Movement Disorders 'ReSTaRt' Unit, Physical Medicine and Rehabilitation Section, Policlinico Riuniti Hospital, University of Foggia, 71122 Foggia, Italy.

Marco Battaglia (M)

Physical and Rehabilitative Medicine, Department of Health Sciences, University of Eastern Piedmont "A. Avogadro", 28100 Novara, Italy.

Alessio Baricich (A)

Physical and Rehabilitative Medicine, Department of Health Sciences, University of Eastern Piedmont "A. Avogadro", 28100 Novara, Italy.

Andrea Santamato (A)

Spasticity and Movement Disorders 'ReSTaRt' Unit, Physical Medicine and Rehabilitation Section, Policlinico Riuniti Hospital, University of Foggia, 71122 Foggia, Italy.

Nicola Smania (N)

Department of Neurosciences, Biomedicine and Movement Sciences, University of Verona, 37100 Verona, Italy.

Alessandro Picelli (A)

Department of Neurosciences, Biomedicine and Movement Sciences, University of Verona, 37100 Verona, Italy.
Canadian Advances in Neuro-Orthopedics for Spasticity Consortium (CANOSC), Kingston, ON K7K 1Z6, Canada.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH